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Programmable meroterpene synthesis
Xingyu Shen1,2, Chi P. Ting 1,2, Gong Xu 1 & Thomas J. Maimone 1*
The bicyclo[3.3.1]nonane architecture is a privileged structural motif found in over 1000
natural products with relevance to neurodegenerative disease, bacterial and parasitic infec-
tion, and cancer among others. Despite disparate biosynthetic machinery, alkaloid, terpene,
and polyketide-producing organisms have all evolved pathways to incorporate this carbo-
cyclic ring system. Natural products of mixed polyketide/terpenoid origins (meroterpenes)
are a particularly rich and important source of biologically active bicyclo[3.3.1]nonane-con-
taining molecules. Herein we detail a fully synthetic strategy toward this broad family of
targets based on an abiotic annulation/rearrangement strategy resulting in a 10-step total
synthesis of garsubellin A, an enhancer of choline acetyltransferase and member of the large
family of polycyclic polyprenylated acylphloroglucinols. This work solidifies a strategy for
making multiple, diverse meroterpene chemotypes in a programmable assembly process
involving a minimal number of chemical transformations.
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Nature remains the consummate master assembler ofintricate polycyclic molecules, and natural products have—and continue to—provide the impetus for the design
and discovery of many of the strategies and tactics pertinent to
ring formation in organic synthesis1. Embedded in over 1000
natural products is the bicyclo[3.3.1]nonane ring system, which
provides a unique spatial arrangement for up to 16 potential
substituents to decorate its periphery (Fig. 1a). Despite the sig-
nificant differences in synthesis capabilities between alkaloid,
terpene, and polyketide biosynthetic machinery, all of these nat-
ural product classes claim bicyclo[3.3.1]nonane-containing
members. Examples include the neuroprotective alkaloid huper-
zine (1), unusual sesquiterpene upial (2), cytotoxic limonoid
mexicanolide (3), and the anti-malarial polyketide rugulosone (4).
Owing to both their sheer number as well as biological
importance, polyketide/terpenoid hybrids (meroterpenes) repre-
sent the flagship subset of bicyclo[3.3.1]nonane-containing nat-
ural products (Fig. 1b). Metabolites formed through the coupling
of isoprenoid side chains with either 3,5-dimethylorsellinic
acid (DMOA)2 or acylphloroglucinol derivatives3,4 constitute the
majority of such members. The DMOA-derived members ber-
keleyone A (5) and berkeleydione (6), which possess anti-
inflammatory and caspase-1 inhibitory properties5,6, and the
neuroactive polycyclic polyprenylated acylphloroglucinols
(PPAPs) hyperforin (7)7 and the garsubellins (8–9)8,9 are repre-
sentative of the structural complexity these targets possess.
Moreover, PPAPs in particular induce wide and diverse biological
effects and thus represent lead structures for neuroscience,
infectious disease, and oncology drug discovery programs4.
Hundreds of bicyclo[3.3.1]nonane-containing PPAPs exists and it
would appear that nature modulates PPAP function by varying
the groups decorating the conserved bicyclo[3.3.1]nonane core.
Yet how function is systematically encoded by these groups
remains enigmatic. While natural products are unquestionably
rich sources of medicinal leads for drug discovery10,11, in most
cases they are still not easily constructed in a step-economical and
components-based mix and match format as is typical in many
drug discovery programs using small, planar compounds con-
nected through C(sp2)–C(sp2) linkages.
Not surprisingly, DMOA-derived meroterpenes12–14, and
especially the PPAPs15–50, have proven to be popular targets for
total synthesis, and a wide range of creative synthetic approa-
ches have been developed for this purpose to date. Herein, we
solidify a broad strategy for bicyclo[3.3.1]nonane-containing
meroterpene construction, which in the case of PPAPs, offers
10-step entry into synthetically challenging and biologically
active type A members in a modular and predictable fashion.
Using this strategy, a few simple fragments can be identified as
the building blocks for a large proportion of family members.
Finally, our work further underscores how following nature’s
molecular design process can lead to efficient abiotic total
synthesis tactics and the development of C–C bond-forming
methodology.
Results
Synthetic design. Nature’s assembly process of PPAPs served as
initial inspiration for our meroterpene synthetic program as it has
for others. Although detailed, enzyme-level blueprints are absent
for complex PPAPs, labeling studies have provided a likely bio-
synthetic scenario, which is shown for the garsubellin A nucleus
(12) (Fig. 2)51. In the initial polyketide assembly phase, three
molecules of acetyl-CoA (shown in blue) and one molecule of
isobutyryl-CoA (shown in turquoise) are joined and then cyclized
to phloroglucinol 10 (Fig. 2a). Notably, the isobutyryl group can
be swapped with an assortment of other acyl groups leading to
early diversification of the PPAPs. Next, 10 is merged with three
equivalents of dimethylallyl pyrophosphate (shown in green) in a
dearomative alkylation event forming polyprenylated acylphlor-
oglucinol 11. Finally, a fourth molecule of dimethylallyl pyr-
ophosphate activates a single prenyl side chain, leading to a
presumed cationic intermediate that is trapped by the pendant
enol ether event, thus forging two C–C bonds and the hallmark
bicyclo[3.3.1]nonane core (see 12) swiftly from 11. To produce
garsubellin A (8) from 12, a chemo- and diastereoselective oxi-
dation of a single prenyl side chain can be invoked followed by
regioselective opening of the epoxide by the pendant vinylogous
acid. Overall, nine C–C bonds are forged in only a few steps.
Our approach toward PPAPs, including 8, did not seek to
emulate nature’s reaction pathway, but rather took inspiration
from the basic building blocks employed (Fig. 2b). In particular,
the use of fully intact prenyl groups in the construction of PPAPs
had great synthetic appeal both for elegance and simplicity
reasons. We envisioned that 2-methylcyclopentenone (shown in
blue) could be converted into ketone 13 via straightforward
conjugate addition and enolate alkylation chemistry, involving
two prenyl equivalents (shown in green) and a one-carbon
electrophile (shown in orange). From this simple, but highly
substituted, cyclopentanone building block, a reaction was desired
that could append on a 4-carbon 1,3-diketone equivalent
generating 5,6-fused bicycle 14 in analogy to the Robinson-
annulation process, but employing an electrophile of a higher
oxidation state. From 14, a formal oxidative isomerization of the
5,6-fused skeleton could construct the bicyclo[3.3.1]nonane
skeleton directly (see 14 to 15). Finally, late-stage scaffold-
decorating steps, in this case attachment of the final prenyl group
and isobutyryl unit, would generate 12. In this approach, seven
C–C bonds could be forged in a minimal number of steps.
Enolate annulation chemistry. A major hurdle in the imple-
mentation of the proposed reaction plan was the four-carbon
annulation reaction. Our efforts began with the identification and
optimization of a suitable coupling reagent capable of reacting
with the enolate of ketone 16 itself, prepared in three steps
(Fig. 3a)43. Cyclopentanone 16 represents one of the two building
blocks that comprise the majority of the PPAPs amenable to our
abiotic strategy (vide infra). After significant experimentation, we
identified the strained, feedstock chemical diketene (see Supple-
mentary Note 1 for preparation) as a unique and highly reactive
four-carbon unit capable of forming bicycle 17 in 11% yield (see
Fig. 3a inset, entry 1). Lithium enolates were found to be critical
in this process, which also formed C-acylated, but uncyclized,
product 18 (3%) as well as O-acylated product 19 (17%). Similar
results were also obtained using lithium hexamethyldisilazide
(LHMDS) as base (see Fig. 3a inset, entry 2). Given the ability of
diketene to react with diisopropylamine, we also evaluated tert-
Butyllithum (t-BuLi) and lithium tetramethylpiperidine (LTMP)
as bases finding both boosted the amount of annulated product
formed (see Fig. 3a inset, entries 3 and 4). In an effort to reduce
the O-acylation product, we evaluated ethereal solvents of varying
polarity. Although pure diethyl ether showed promise in this
regard (see Fig. 3a inset, entry 5), the reaction efficiency was low
and almost equal amounts of 17 and 18 were formed highlighting
the importance of solvent in the ring-closing step. A variety of
mixed ethereal solvents were examined (see Fig. 3a inset, entries
6–8) ultimately arriving at an optimal THF/Et2O mixture for this
specific substrate. After temperature optimization, we were able
to produce 17 in 35% isolated yield and as a single diastereomer.
It should be stressed that diketene is a highly unique reagent in
this annulation process. A variety of other four-carbon con-
junctive reagents (see 20–25), including the unstrained diketene
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14354-5
2 NATURE COMMUNICATIONS |          (2020) 11:508 | https://doi.org/10.1038/s41467-020-14354-5 | www.nature.com/naturecommunications
acetone adduct (21) as well as substituted diketenes (24), were all
examined and did not produce the desired cyclic product.
The annulation reaction of lithium enolates proved amenable
to the preparation of a variety of diverse, cyclic 1,3-diketones
(Fig. 3b). The starting enolates can be generated by either reacting
the free ketone with strong base (LTMP) or by treating the
corresponding silyl enol ether derivative with methyllithium
(see Supplementary Notes 3 and 4). Cyclopentanones with
varying C-5, C-7, and C-8 substitution patterns (see products
26–29) were tolerated, highlighting how different inputs can be
easily inserted into our PPAP synthetic blueprint. Sterically
congested polycycle 30 was also formed in 30% and forms the
basis for a DMOA-derived meroterpene synthetic program13,14.
Diketones 31 and 32, which contain a gem-dimethyl group in
close proximity to either an isopropyl or phenyl substituent also
highlight the ability of this method to forge highly hindered C–C
linkages. A variety of propio- or butyrophenone derivatives with
diverse substituents were also annulated, leading to cyclic
products 33–42 in good yields (30–65%) and with high
diastereoselectivity. We attribute the lower isolated yield of
product 42 to poor lithium enolate solubility in the ethereal
solvent mixture employed. Cyclic aliphatic ketones could also be
annulated leading to products 43 and 44; a small preference for
the trans diastereomer was noted in these cases. Cyclic enone-
containing natural products, such as carvone and nootkatone,
could be annulated to produce adducts 45 and 46, respectively.
All of the compounds prepared using this chemistry were
previously inaccessible chemical entities.
The total synthesis of garsubellin A. Although we had pre-
viously employed building block 16 in a short synthesis of the
antidepressant PPAP hyperforin (7)43, we turned our attention
toward garsubellin A (8). In a search for naturally occurring small
molecules to treat neurodegenerative disease, Fukuyama and
co-workers isolated 8 from the wood of Garcinia subelliptica,
finding that it increased choline acetyltransferase (ChAT)
levels 154% relative to control in P10 rat septal neurons8.
Notably, ChAT is attenuated in neurological pathologies such as
Alzheimer’s disease52,53.
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Fig. 2 Approaches to the synthesis of bicyclo[3.3.1]nonane-containing meroterpenes. a Nature’s presumed synthetic route employing polyketide
assembly of an aromatic precursor followed by various C–C bond-forming prenylation events. b An abiotic synthetic strategy allows for similarly rapid and
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Fig. 1 Complex bicyclo[3.3.1]nonane-containing natural products. a Members are found across all areas of natural product space and therapeutic area. b
The large family of terpene-polyketide hybrids (meroterpenes) as a particularly prolific sources of bicyclo[3.3.1] nonanes.
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Not surprisingly, garsubellin A has attracted substantial world-
wide synthetic interest20,54–59, yet to date, only the groups of
Shibasaki15, Danishefsky16, and Nakada36 have documented full
total syntheses of this target. Unlike hyperforin, in 8 a single
prenyl side chain has been chemo- and stereoselectively oxidized
and then cyclized resulting in a complex cyclic ether motif.
Mimicking similar oxidative processes in the laboratory in a
diastereo-controlled manner has proven challenging in a number
of contexts15,20,36,37, and given the presence of garsubellins C and
D in Garcinia subelliptica (see 9, Fig. 1)9. Nature may also struggle
with this problem in regio- and stereoselective chemical synthesis.
Notably, isomers 9 are not reported as ChAT enhancers.
Synthesis of the key THF substructure. We began our synthetic
efforts by preparing key diprenylated cyclopentanone building
block 48 (Fig. 4). In doing so, we developed a straightforward
route to this motif, diverging from our previous conjugate addi-
tion strategy used to produce 16. Thus, commercially available
2-methyl-cyclopenten-1-one was first α-alkylated with prenyl
bromide and then treated with prenylmagnesium chloride indu-
cing a highly diastereoselective reverse ketone prenylation. The
sterically congested tertiary alcohol formed (see 47) then under-
went a facile anionic oxy-Cope rearrangement when exposed to
potassium hydride and 18-crown-6. After treatment with MgBr2,
the resulting magnesium enolate was alkylated at carbon with
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methyl iodide affording 48. Small amounts (~10%) of the
regioisomeric alkylation product as well doubly alkylated mate-
rials were also formed in this transformation; whereas these
materials could not be cleanly separated by silica gel chromato-
graphy, they were effectively removed following the subsequent
transformation. To that effect, employing the diketene annulation
on the lithium enolate derived from ketone 48 smoothly gener-
ated 5,6-fused bicycle 49 in 44% isolated yield and as a single
diastereomer; interestingly, this process was noticeably more
efficient than with the related ketone 16.
Although a number of synthetic intermediates could be
imagined as suitable starting points for construction of the key
tetrahydrofuran (THF) motif embedded in garsubellin A, our
final successful route incorporated this structure from bicycle 49
(Fig. 4). After extensive experimentation, we found that catalytic
quantities of palladium acetate in the presence of a stoichiometric
copper-based oxidant (Cu(OAc)2) led to the formation of 52 as a
single diastereomer (confirmed by X-ray crystallographic analy-
sis) in very high yield (95%), presumably via an unusual Wacker-
type cyclization of the vinylogous acid (see 50→51→52, only an
anti-oxypalladation pathway is depicted for simplicity)60. Typi-
cally Pd(II)-activated alkenes are attacked by the carbon atom of
1,3-dicarbonyl-containing compounds61–64, but geometric con-
straints presumably disfavor this process in this system.
The construction of this cyclic ether motif has previously
proven challenging to access by epoxidation of a prenyl side chain
and acid-promoted cyclization–poor diastereoselectivity in the
oxidation has historically led to low overall efficiency15,20,36.
Moreover, facile oxidative degradation of PPAPs further
complicates such transformations. We also encountered similar
problems in our exploratory studies toward this key ring (see
Fig. 4 inset). A variety of oxidation conditions were evaluated
on 1,3-diketone-containing substrate 49 or its corresponding
vinylogous methylester (53). Epoxidation (m-CPBA, DMDO, or
VO(acac)2/TBHP) and dihydroxylation (OsO4) conditions all
afforded complex reaction mixtures containing cyclized and non-
cyclized materials; a poorly diastereoselective and chemoselective
oxidation was noted here as well (see Fig. 4 inset, entries 1–4).
Seeking to avoid these reaction shortcomings, we reasoned that
activation of the prenyl group and direct cyclization by the
pendant vinylogous acid in an overall oxidative process would be
a more prudent strategy. Interestingly, we initially discovered that
treatment of 53 with Koser’s reagent (PhI(OH)OTs) in mixtures
of hexafluoroisopropanol/water could promote the direct forma-
tion of tertiary alcohol 54 (25%) along with alkene 52 (40%) (see
Fig. 4 inset, entry 6). Notably, the other electronically similar
prenyl group was not oxidized, suggesting this process involved
π-bond activation and cyclization; unfortunately, we were unable
to further bias the reaction profile toward 54. Of note, the free
1,3-diketone (i.e., 49) reacted to form an iodonium ylide under
related conditions (see Fig. 4 inset, entry 5). Ultimately, these
findings assisted in the discovery of the high-yielding Pd(II)-
catalyzed oxidative cyclization of 49–52 (see Fig. 4 inset, entry 7).
Completion of a 10-step synthesis of garsubellin A. With a
robust, five-step route to tricycle 52, we were poised to evaluate
the second key transformation in our programmable route to
meroterpenes, namely oxidative isomerization of the 5,6-fused
bicycle to the bicyclo[3.3.1]nonane (Fig. 5)13,43. Despite the pre-
sence of the additional rigidifying THF ring, treatment of this
substrate with (diacetoxyiodo)benzene under basic conditions
cleanly forged bicyclo[3.3.1]nonane 55 in good yield (75%). Cobalt
(II)-salen-catalyzed Mukaiyama hydration of 55 chemoselectively
furnished a tertiary alcohol, which could be silylated in the same
pot (TMSCl, imidazole, DMAP) to afford 5665. Chlorination of
the C-2 position (LTMP, TsCl) allowed for the challenging
bridgehead (i.e., C-6) functionalization process (LTMP then
i-PrCOCl) to proceed smoothly (see 57→58)66. We note that in
prior work toward hyperforin, only one of two possible vinylogous
ester regioisomers took part in the bridgehead deprotonation
reaction, an unfortunate finding since they were formed
unselectively43,67. By incorporating the THF ring prior to the C-6
deprotonation, this problem is obviated in this context16,18.
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With 58 in hand, all that remained was C-2 prenylation and
cleavage of the silyl ether. Transition metal-catalyzed cross-
coupling methods offer perhaps the most-attractive solution to
this problem owing to their potential for easy and rapid
compound diversification late-stage. Yet palladium-catalyzed
cross-coupling methods, especially direct prenylation, have
historically proven challenging on similar bicyclo[3.3.1]
nonane-containing PPAP scaffolds and we assumed deactivated
vinyl chloride 58 would be no different15. Although recent
advances in ligand-controlled, linear-selective prenylation meth-
odology boded well for such endeavors68–70, the sensitivity of
vinylogous ester 58 to hydrolysis and base-induced decomposi-
tion proved problematic. After significant experimentation, we
successfully applied Buchwald’s Pd/CPhos-system71 to the Suzuki
coupling of 58 and prenylBpin, affording garsubellin A (8)
directly in 57% yield. It should be noted that the successful
reactivity window for this transformation was minute and
deviating even slightly from the optimized conditions proved
quite deleterious. For example, heating the reaction mixture for 8
h instead of four led to an ~10% yield. Similarly, changing the
solvent mixture from 1:1 dioxane:H2O to 4:1 dioxane:H2O lead
primarily to reduction of the vinyl chloride. A small amount of
material (17%) still containing the TMS group (see 59) was also
formed under our optimized conditions, but can be converted
into 8 via the procedure of Danishefsky16. Overall, the synthesis
of 8 required 10 steps (3% overall yield) and is nearly half the
steps of the previously reported shortest total synthesis of this
complex PPAP.
Discussion
The described total synthesis of garsubellin A combined with our
prior work on hyperforin and the DMOA-derived meroterpene
berkeleyone A solidifies a general strategy for bicyclo[3.3.1]non-
ane-containing meroterpene construction and reduces the com-
plexity of many of these targets to that of a substituted
cyclopentanone. Recent scholarly analyses of all PPAPs by
Grossman and Xu highlighted ~350 natural products with intact
bicyclo[3.3.1]nonane ring systems, which can be classified as
either type A or type B, depending on the placement of the acyl
group (Fig. 6)3,4. More than half of these members are further
designated “exo-type” PPAPs (see 60 and 61, Fig. 6) signifying
that the C-7 substituent resides on the same face as the C-9
carbonyl group as is found in garsubellin and hyperforin. From
the exo-type A grouping, of relevance to the work demonstrated
herein, we estimate that only four building blocks, namely 16, 48,
62, and 63 are required to access over 90% of members using the
strategy documented here in combination with side chain
manipulations. Moreover, building blocks 16 and 48 alone, which
we have already successfully employed, cover over 75% of exo-
Type A PPAP space. In broader terms, our work in combination
with Porco’s efficient biomimetic assembly of type B PPAPs40,
and Plietker’s modular route to endo-type PPAPs30,37,38, means
that a large swath of all of PPAP chemical space can potentially be
covered synthetically in ten or fewer steps.
We note in closing that calls to increase three-dimensional
complexity in drug discovery programs are intensifying72, further
highlighting the need for modular routes to spatially multifaceted
small molecules in rapid fashion. Nature routinely provides such
complexity, and in many cases, also clues to its synthetic design
and diversification process. Although directly mimicking such
chemistry in the laboratory can prove fruitful, abiotic synthesis
strategies also offer opportunities for new reaction discovery and
the prospect of accessing diverse naturally occurring secondary
metabolites and their derivatives with efficiencies that rival nature.
Methods
General. All air and moisture sensitive reactions were performed in flame-dried
glassware under an atmosphere of dry nitrogen or argon. Dry THF, dichlor-
omethane, diethyl ether, toluene, dimethylformamide, and hexane were obtained
by passing these previously degassed solvents through activated alumina columns.
When mentioned, further solvent degassing was performed by bubbling a stream of
argon through the solvent in an ultrasound bath for a period of 10 min. Anhydrous
dimethyl sulfoxide was purchased from Aldrich, stored over molecular sieves, and
used without further purification. All other reagents were used as received, unless
stated otherwise. Reactions were monitored by thin-layer chromatography (TLC)
on Silicycle SiliaplateTM glass backed TLC plates (250 μm thickness, 60 Å porosity,
F-254 indicator) and visualized by UV irradiation or development with an ani-
saldehyde or phosphomolybdic/cerium sulfate stain. Volatile solvents were
removed under reduced pressure with a rotary evaporator. All flash column
chromatography was performed using Silicycle SiliaFlash F60, 230–400 mesh silica
gel (40–63 μm). 1H NMR and 13C NMR spectra were recorded with Bruker AV,
AVQ, and DRX spectrometers operating at 400, 500, 600, or 700MHz for 1H (100,
125, 150, 175MHz for 13C) in CDCl3, C6D6, CD2Cl2, CD3OD, or (CD3)2CO.
Chemical shifts are reported relative to the residual solvent signal (1H NMR: δ=
7.26 (CDCl3); 13C NMR: δ= 77.16 (CDCl3)). NMR data are reported as follows:
chemical shift (multiplicity, coupling constants where applicable, number of
hydrogens). Splitting is reported with the following symbols: s= singlet, bs= broad
singlet, d= doublet, t= triplet, app t= apparent triplet, dd= doublet of doublets,
ddd= doublet of doublet of doublets, dt= doublet of triplets, hept= heptet,
52
59 58 57
55 56
98%
65%
Garsubellin A (8)
TBAF [ref. 16 ]
[(allyl)PdCl]2
CPhos
K3PO4
1:1 dioxane/H2O
110 °C
57% 8 + 16% 59
LTMP
TsCI
LTMP
i-PrCOCl
[Co], O2
PhSiH3;
1,2-cyclohexanediaminocobalt(II)
[Co] = (S,S)-(+)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-
KOH, MeOH
Phl(OAc)2 (–Phl )
75% TMSCI, imidazole
DMAP, DMF
72%
Fig. 5 Total synthesis of garsubellin A. An oxidative ring expansion constructs the key bicyclo[3.3.1] nonane core framework and enables a 10-step route
to the target.
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m=multiplet. IR spectra were recorded on a Nicolet 380 spectrometer as thin
films and are reported in frequency of absorption (cm−1). High-resolution mass
spectra were obtained by the mass spectrometry facility at the University of
California, Berkeley using a Finnigan LTQ FT mass spectrometer.
Experimental data. For experimental procedures and spectroscopic data of the
compounds, see Supplementary Information. For general procedures for preparing
diketene and its employment in enolate annulations, see Supplementary Notes 1–4
and Supplementary Fig. 1. For general procedures to prepare garsubellin A and
intermediates, see Supplementary Fig. 2 and Supplementary Note 5. For NMR
spectra of synthetic intermediates, see Supplementary Figs. 3–70. For the com-
parison of synthetic and natural garsubellin A NMR spectra see Supplementary
Tables 1–2, Supplementary Fig. 71, and the Supplementary References.
Data availability
The X-ray crystallographic coordinates for structures 30, 33, 46, 44, and 52 have
been deposited at the Cambridge Crystallographic Data Centre (CCDC) with the
accession codes CCDC #1521625, 1521624, 1956231, 1521627, and 1879639,
respectively. (www.ccdc.cam.ac.uk/data_request/cif). All other relevant data
supporting the findings of this study are available within the article and its
Supplementary Information files.
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